Jeff E. Knight, Chief Operating Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 501 shares at $56.52 ($28K) on 2024-11-22, disclosed to the SEC on 2024-11-26.
Scheduled sale ($28k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CRNX | SELL | 2025-03-21 | $477K | — | Filing → |
| CRNX | SELL | 2024-07-17 | $1.5M | — | Filing → |
| CRNX | SELL | 2024-06-28 | $42K | — | Filing → |